105 related articles for article (PubMed ID: 3032527)
1. Inhibitory effect of Azone (1-dodecylazacycloheptan-2-one) on herpes simplex viruses. In vivo and in vitro studies.
Leonard MF; Kumar A; Murray DL; Beaman DC
Chemotherapy; 1987; 33(2):151-6. PubMed ID: 3032527
[TBL] [Abstract][Full Text] [Related]
2. Effect of Azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice.
Afouna MI; Fincher TK; Zaghloul AA; Reddy IK
Int J Pharm; 2003 Mar; 253(1-2):159-68. PubMed ID: 12593946
[TBL] [Abstract][Full Text] [Related]
3. Effect of azone and propylene glycol on penetration of trifluorothymidine through skin and efficacy of different topical formulations against cutaneous herpes simplex virus infections in guinea pigs.
Spruance SL; McKeough M; Sugibayashi K; Robertson F; Gaede P; Clark DS
Antimicrob Agents Chemother; 1984 Dec; 26(6):819-23. PubMed ID: 6441511
[TBL] [Abstract][Full Text] [Related]
4. Influence of 1-dodecylazacycloheptan-2-one (Azone) on the topical therapy of cutaneous herpes simplex virus type 1 infection in hairless mice with 2',3'-di-O-acetyl-9-beta-D-arabinofuranosyladenine and 5'-O-valeryl-9-beta-D-arabinofuranosyladenine.
Shannon WM; Westbrook L; Higuchi WI; Sugibayashi K; Baker DC; Kumar SD; Fox JL; Flynn GL; Ho NF; Vaidyanathan R
J Pharm Sci; 1985 Nov; 74(11):1157-61. PubMed ID: 4087174
[TBL] [Abstract][Full Text] [Related]
5. Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2'-deoxyuridine cream.
Freeman DJ; Sacks SL; De Clercq E; Spruance SL
Antiviral Res; 1985 Jun; 5(3):169-77. PubMed ID: 2992371
[TBL] [Abstract][Full Text] [Related]
6. Topical treatment of cutaneous herpes simplex virus infection in hairless mice with (E)-5-(2-bromovinyl)-2'-deoxyuridine and related compounds.
de Clercq E
Antimicrob Agents Chemother; 1984 Aug; 26(2):155-9. PubMed ID: 6486759
[TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of 5-ethyl-2'-deoxyuridine against herpes simplex viruses in cell culture, mice, and guinea pigs.
Schinazi RF; Scott RT; Peters J; Rice V; Nahmias AJ
Antimicrob Agents Chemother; 1985 Oct; 28(4):552-60. PubMed ID: 3000291
[TBL] [Abstract][Full Text] [Related]
8. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
Schuhmacher A; Reichling J; Schnitzler P
Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235
[TBL] [Abstract][Full Text] [Related]
9. Thiosemicarbazones of 2-acetylpyridine, 2-acetylquinoline, 1-acetylisoquinoline, and related compounds as inhibitors of herpes simplex virus in vitro and in a cutaneous herpes guinea pig model.
Shipman C; Smith SH; Drach JC; Klayman DL
Antiviral Res; 1986 Jul; 6(4):197-222. PubMed ID: 3017201
[TBL] [Abstract][Full Text] [Related]
10. Antiviral activity of Australian tea tree oil and eucalyptus oil against herpes simplex virus in cell culture.
Schnitzler P; Schön K; Reichling J
Pharmazie; 2001 Apr; 56(4):343-7. PubMed ID: 11338678
[TBL] [Abstract][Full Text] [Related]
11. Antiviral susceptibilities of herpes simplex virus isolates from infants with recurrent mucocutaneous lesions after neonatal infection.
Rabalais GP; Nusinoff-Lehrman S; Arvin AM; Levin MJ
Pediatr Infect Dis J; 1989 Apr; 8(4):221-3. PubMed ID: 2541398
[TBL] [Abstract][Full Text] [Related]
12. Effect of chlorhexidine on the in vitro and in vivo herpes simplex virus infection.
Park JB; Park NH
Oral Surg Oral Med Oral Pathol; 1989 Feb; 67(2):149-53. PubMed ID: 2537483
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo antiviral activity of 2'-fluorinated arabinosides of 5-(2-haloalkyl)uracil.
Rosenwirth B; Streicher W; De Clercq E; Wanek E; Schwarz W; Griengl H
Antiviral Res; 1987 Jun; 7(5):271-87. PubMed ID: 2821896
[TBL] [Abstract][Full Text] [Related]
14. Influence of vehicle on topical efficacy of 2-acetylpyridine thiosemicarbazone and related derivatives on in vivo type 2 herpes simplex virus infections.
Sidwell RW; Huffman JH; Schafer TW; Shipman C
Chemotherapy; 1990; 36(1):58-69. PubMed ID: 2155092
[TBL] [Abstract][Full Text] [Related]
15. [Biological effects of coordinated compounds of transitional metals. 7. Antiviral activity of 4-methyl-2-aminopyridine palladium chloride against herpes simplex virus type 1 and type 2 in vitro and in vivo].
Wutzler P; Thiel KD; Tonew M; Tonew E; Schröer HP; Stelzner A
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Oct; 266(3-4):563-6. PubMed ID: 2830739
[TBL] [Abstract][Full Text] [Related]
16. Failure of 2-deoxy-D-glucose in the treatment of experimental cutaneous and genital infections due to herpes simplex virus.
Kern ER; Glasgow LA; Klein RJ; Friedman-Kien AE
J Infect Dis; 1982 Aug; 146(2):159-66. PubMed ID: 6286785
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol as a Novel Anti-Herpes Simplex Virus Nutraceutical Agent: An Overview.
Annunziata G; Maisto M; Schisano C; Ciampaglia R; Narciso V; Tenore GC; Novellino E
Viruses; 2018 Sep; 10(9):. PubMed ID: 30177661
[TBL] [Abstract][Full Text] [Related]
18. Anti-viral activity of the extracts of a Kenyan medicinal plant Carissa edulis against herpes simplex virus.
Tolo FM; Rukunga GM; Muli FW; Njagi EN; Njue W; Kumon K; Mungai GM; Muthaura CN; Muli JM; Keter LK; Oishi E; Kofi-Tsekpo MW
J Ethnopharmacol; 2006 Mar; 104(1-2):92-9. PubMed ID: 16198524
[TBL] [Abstract][Full Text] [Related]
19. Acyclovir topical therapy of cutaneous herpes simplex virus infection in guinea pigs.
Park NH; Pavan-Langston D; McLean SL; Lass JH
Arch Dermatol; 1980 Jun; 116(6):672-5. PubMed ID: 7377804
[TBL] [Abstract][Full Text] [Related]
20. Antiherpes effects and pharmacokinetic properties of 9-(4-hydroxybutyl) guanine and the (R) and (S) enantiomers of 9-(3,4-dihydroxybutyl)guanine.
Ericson AC; Larsson A; Aoki FY; Yisak WA; Johansson NG; Oberg B; Datema R
Antimicrob Agents Chemother; 1985 May; 27(5):753-9. PubMed ID: 2990325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
